Published • loading... • Updated
First Commercial Alzheimer’s Tau Tangle Blood Test Launches
Summary by Clinical Lab Products
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
First Commercial Alzheimer’s Tau Tangle Blood Test Launches
The eMTBR-Tau assay measures tau tangle pathology in blood, with potential applications in Alzheimer’s disease staging, clinical trials, and therapy monitoring. Alamar Biosciences has launched the first commercial eMTBR-Tau immunoassay, a blood-based test designed to measure tau tangle pathology in Alzheimer’s disease. The assay is available in the NULISAseq Neuro 220 multiplexed panel kits for use on the ARGO HT instrument base and as a single-…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
